A robotic arm brace designed to help stroke patients relearn how to move affected muscles and regain use of paralysed limbs has been approved by the US Food and Drug Administration, device maker Myomo Inc. have announced.
The Boston-based company said it would start marketing the e100 Neurorobotic System to medical specialists and rehabilitation clinics, the Associated Press reported. It's expected that the device will cost $5,000 to $10,000.
The brace slides onto the arm and sensors in the brace detect muscle contractions. This triggers a motor that allows patients to control their arm movement. The motor is located in a backpack worn by the patient.
The brace does require invasive procedures and does not use electrical stimulation. It's meant to help stroke patients use their own biological signals to regain muscle control and movement, the AP reported. – (HealthDayNews)